Literature DB >> 30486667

A Case Series of Granulomatosis With Polyangiitis Primarily Diagnosed by Otological Manifestations.

Ronald Sahyouni1,2, Omid Moshtaghi1, Mehdi Abouzari1, Phuonganh Le1, Jack Birkenbeuel1, Dillon Cheung1, Harrison W Lin1, Hamid R Djalilian1,2.   

Abstract

OBJECTIVE: To describe a case series of previously undiagnosed granulomatosis with polyangiitis (GPA) patients who presented primarily with otological manifestations.
METHOD: We report a series of patients visited at a neurotology clinic who were eventually diagnosed with GPA based on their otologic complaints and had no prior knowledge of having this condition.
RESULTS: In this series, 10 (91%) patients presented with hearing loss (HL), more than half of which were bilateral (60%). Upon audiometric examination, all but 1 patient had mixed, conductive, or sensorineural HL. All patients presented with eustachian tube dysfunction (ETD), otitis media with effusion (OME), or both. Nasal endoscopy showed intranasal pathology in 3 (27%) patients. Otologic symptoms were improved in all patients after treatment with an average of 4 in-office follow-up appointments.
CONCLUSION: GPA should be included in the differential diagnosis of adults with unexplained mixed hearing loss, new onset serous effusion, or acute otitis media in the absence of a previous history of ETD. Laboratory tests (ie, anti-neutrophil cytoplasmic autoantibody, erythrocyte sedimentation rate, and C-reactive protein) along with a urinalysis can aid in screening these patients. In cases in which the index of suspicion is high, repeated testing could reduce the risk of false negative findings.

Entities:  

Keywords:  ANCA associated vasculitis; Wegener’s granulomatosis; granulomatosis with polyangiitis; hearing loss; otology

Mesh:

Year:  2018        PMID: 30486667     DOI: 10.1177/0003489418815517

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  1 in total

1.  Granulomatosis With Polyangiitis Presenting as Complete Hearing Loss.

Authors:  Brandon H Busch; David Wilhelm; Paul Johnson; Mark Pfeifer
Journal:  Cureus       Date:  2022-05-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.